All 48 KURE (KRANESHARES MSCI ALL CHINA HEALTH CARE INDEX ETF) Holdings
There are 48 KURE holdings. Top 10 companies weight: 52.31%.
Total Market Cap: $4.26B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (48 stocks) | -13.49% | 149.25 | +139.68% | -13.38% | 0.49 | ||||||||||||
1 | n/a | Innovent Biologics Inc | 8.73% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
2 | n/a | Beone Medicines Ltd Ordinary Shares | 8.63% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
3 | n/a | Wuxi Biologics (cayman) Inc | 7.46% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
4 | n/a | Wuxi Apptec Co Ltd Class A | 5.29% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
5 | n/a | Jiangsu Hengrui Pharmaceuticals Co Ltd Class A | 4.32% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
6 | n/a | Shenzhen Mindray Bio-medical Electronics Co Ltd Class A | 3.96% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
7 | n/a | Akeso Inc Ordinary Shares | 3.76% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
8 | n/a | Sino Biopharmaceutical Ltd | 3.54% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
9 | n/a | Cspc Pharmaceutical Group Ltd | 3.52% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
10 | n/a | Wuxi Apptec Co Ltd | 3.10% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
11 | n/a | Cash | 2.99% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
12 | n/a | Hansoh Pharmaceutical Group Co Ltd | 2.85% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
13 | n/a | 3sbio Inc Shs Unitary 144a/reg S | 2.33% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
14 | n/a | Shanghai United Imaging Healthcare Co Ltd Class A | 2.22% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
15 | n/a | Yunnan Baiyao Group Co Ltd Class A | 2.19% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
16 | n/a | Sichuan Kelun-biotech Biopharmaceutical Co Ltd Class H Shares | 1.93% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
17 | n/a | Aier Eye Hospital Group Co Ltd Class A | 1.91% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
18 | n/a | Sichuan Kelun Pharmaceutical Co Ltd Class A | 1.90% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
19 | n/a | Zhangzhou Pientzehuang Pharmaceutical Co Ltd Class A | 1.89% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
20 | n/a | Sichuan Biokin Pharmaceutical Co Ltd Class A | 1.84% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
21 | n/a | Sinopharm Group Co Ltd | 1.61% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
22 | n/a | Haisco Pharmaceutical Group Co Ltd Class A | 1.43% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
23 | n/a | Pharmaron Beijing Co Ltd Class A | 1.31% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
24 | n/a | Huadong Medicine Co Ltd Class A | 1.29% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
25 | n/a | Shanghai Allist Pharmaceuticals Co Ltd Class A | 1.29% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
26 | n/a | Wuxi Xdc Cayman Inc | 1.25% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
27 | n/a | Shanghai Fosun Pharmaceutical (group) Co Ltd Class A | 1.24% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
28 | n/a | Genscript Biotech Corp Class H | 1.21% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
29 | n/a | Remegen Co Ltd Class A | 1.16% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
30 | n/a | Shanghai Pharmaceuticals Holding Co Ltd Class A | 1.13% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
31 | LEGN | Legend Biotech Corp Adr | 1.09% | $23.21 | $4.26B | Biotechnology | Healthcare | -13.49% | N/A | 149.25 | N/A | N/A | N/A | 80 | +139.68% | $56 | -13.38% | 0.49 |
32 | n/a | Remegen Co Ltd Class H | 1.09% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
33 | n/a | China Resources Sanjiu Medical & Pharmaceutical Co Ltd Class A | 1.02% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
34 | n/a | Shenzhen Salubris Pharmaceuticals Co Ltd Class A | 0.99% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
35 | n/a | Xtalpi Holdings Ltd | 0.91% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
36 | n/a | Shenzhen New Industries Biomedical Engineering Co Ltd Class A | 0.84% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
37 | n/a | Beijing Tongrentang Co Ltd Class A | 0.83% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
38 | n/a | Cspc Innovation Pharmaceutical Co Ltd Class A | 0.81% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
39 | n/a | Shanghai Raas Blood Products Co Ltd Class A | 0.78% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
40 | n/a | Changchun High-tech Industry (group) Co Ltd Class A | 0.71% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
41 | n/a | Chongqing Zhifei Biological Products Co Ltd Class A | 0.71% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
42 | n/a | Apt Medical Inc Class A | 0.70% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
43 | n/a | Imeik Technology Development Co Ltd Class A | 0.63% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
44 | n/a | Beijing Wantai Biological Pharmacy Enterprise Co Ltd Class A | 0.63% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
45 | n/a | Hebei Changshan Biochemical Pharmaceutical Co Ltd Class A | 0.55% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
46 | n/a | Hangzhou Tigermed Consulting Co Ltd Class A | 0.41% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
47 | n/a | Hong Kong Dollar | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
48 | n/a | Kangmei Pharma Rights O | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
KURE (KRANESHARES MSCI ALL CHINA HEALTH CARE INDEX ETF) Sector Allocation
HEALTHCARE
1.10%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%